Research Article| Volume 190, P25-31, March 01, 2023

Anesthesia-Induced Intraprocedural Downgrading of Mitral Regurgitation During Transcatheter Edge-to-Edge Repair

Published:December 20, 2022DOI:
      During transcatheter edge-to-edge repair (TEER), the reduction of functional mitral regurgitation (FMR) severity, compared with baseline evaluation, is not uncommon. Because the procedural strategies are mainly guided by the location and severity of the regurgitant jets, intraprocedural downgrading (ID) of regurgitation severity could affect the procedural strategy and the results. The aim of this study was to evaluate the prevalence of ID during TEER and to compare early and midterm outcomes in patients with and without ID. All patients with moderate-to-severe or severe FMR who underwent TEER in San Raffaele Hospital between 2018 and 2020 were evaluated in this single-center, retrospective study. ID was defined as mild (1+) or moderate (2+) regurgitation degree during intraprocedural evaluation. The outcomes, assessed at discharge and at 2 years of follow-up, were all-cause mortality, heart failure hospitalization, and recurrence of mitral regurgitation >2+. The final study cohort included 55 patients: 42% presented with ID. At discharge, 85.5% of patients achieved regurgitation reduction to 2+ or less: 100% in patients with ID versus 75% in patients without ID, p <0.009. At 2 years, no significant difference in the incidence of all-cause mortality, heart failure hospitalization, and the recurrence of mitral regurgitation >2+ between patients with ID or without ID was found. In conclusion, ID is frequent during TEER in FMR. No baseline characteristics were found to identify this group of patients. In patients with ID, the combination of live intraprocedural imaging and baseline ambulatory assessment of regurgitant jets seems effective in the procedural guiding to achieve a successful and durable mitral repair.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Zoghbi WA
        • Adams D
        • Bonow RO
        • Enriquez-Sarano M
        • Foster E
        • Grayburn PA
        • Hahn RT
        • Han Y
        • Hung J
        • Lang RM
        • Little SH
        • Shah DJ
        • Shernan S
        • Thavendiranathan P
        • Thomas JD
        • Weissman NJ.
        Recommendations for noninvasive evaluation of native valvular regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.
        J Am Soc Echocardiogr. 2017; 30: 303-371
        • Acker MA
        • Parides MK
        • Perrault LP
        • Moskowitz AL
        • Gelijns AC
        • Voisire P
        • Smith PK
        • Hung JW
        • Blackstone EH
        • Puskas JD
        • Argenziano M
        • Gammie JS
        • Mack M
        • Ascheim DD
        • Bagiella E
        • Moquette EG
        • Ferguson TB
        • Horvarth KA
        • Geller NL
        • Miller MA
        • Woo YJ
        • D'Alessandro DA
        • AIlawadi G
        • Dagenais F
        • Gardner TJ
        • O'Gara PT
        • Michler RE
        • Kron IL
        • CTSN
        Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.
        N Engl J Med. 2014; 370: 23-32
        • Wu AH
        • Aaronson KD
        • Bolling SF
        • Pagani FD
        • Welch K
        • Koelling TM.
        Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.
        J Am Coll Cardiol. 2005; 45: 381-387
        • Scholte AJHA
        • Holman ER
        • Haverkamp MCP
        • Poldermans D
        • Van der Wall EE
        • Dion RAE
        • Bax JJ.
        Underestimation of severity of mitral regurgitation with varying hemodynamics.
        Eur J Echocardiogr. 2005; 6: 297-300
        • Vahanian A
        • Beyersdorf F
        • Praz F
        • Milojevic M
        • Baldus S
        • Bauersachs J
        • Capodanno D
        • Conradi L
        • De Bonis M
        • De Paulis R
        • Delgado V
        • Freemantle N
        • Gilard M
        • Haugaa KH
        • Jeppsson A
        • Juni P
        • Pierard L
        • Prendergast BD
        • Sabada JR
        • Tribouilloy C
        • Wojakowski W
        ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease.
        Eur Heart J. 2022; 43: 561-632
        • Marsan NA
        • Westenberg JJM
        • Ypenburg C
        • Delgado V
        • Van Bommel RJ
        • Roes SD
        • Nucifora G
        • van der Geest RJ
        • de Roos A
        • Reiber JC
        • Schalij MJ
        • Bax JJ.
        Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance.
        JACC Cardiovasc Imaging. 2009; 2: 1245-1252
        • Stone GW
        • Vahanian AS
        • Adams DH
        • Abraham WT
        • Borer JS
        • Bax JJ
        • Schofer J
        • Cutlip DE
        • Krucoff MW
        • Blackstone EH
        • Généreux P
        • Mack MJ
        • Siegel RJ
        • Grayburn PA
        • Enriquez-Sarano M
        • Lancellotti P
        • Filippatos G
        • Kappetein AP
        • Mitral Valve Academic Research Consortium (MVARC)
        Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve Academic Research Consortium.
        J Am Coll Cardiol. 2015; 66: 278-307
        • Asch FM
        • Grayburn PA
        • Siegel RJ
        • Kar S
        • Lim DS
        • Zaroff JG
        • Mishell JM
        • Whisenant B
        • Mack MJ
        • Lindenfeld JA
        • Abraham WT
        • Stone GW
        • Weissman NJ
        • Investigators COAPT
        Echocardiographic outcomes after transcatheter leaflet approximation in patients with secondary mitral regurgitation: the COAPT trial.
        J Am Coll Cardiol. 2019; 74: 2969-2979
        • Goliasch G
        • Bartko PE.
        The paradox of secondary mitral regurgitation: why less is more.
        JACC Cardiovasc Imaging. 2021; 14: 740-741
        • Gisbert A
        • Soulière V
        • Denault AY
        • Bouchard D
        • Couture P
        • Pellerin M
        • Carrier M
        • Levesque S
        • Ducharme A
        • Basmadjian AJ.
        Dynamic quantitative echocardiographic evaluation of mitral regurgitation in the operating department.
        J Am Soc Echocardiogr. 2006; 19: 140-146
        • Sanfilippo F
        • Johnson C
        • Bellavia D
        • Morsolini M
        • Romano G
        • Santonocito C
        • Centineo L
        • Pastore F
        • Pilato M
        • Arcadipane A.
        Mitral regurgitation grading in the operating room: A systematic review and meta-analysis comparing preoperative and intraoperative assessments during cardiac surgery.
        J Cardiothorac Vasc Anesth. 2017; 31: 1681-1691
        • Mahmood F
        • Matyal R
        A quantitative approach to the intraoperative echocardiographic assessment of the mitral valve for repair.
        Anesth Analg. 2015; 121: 34-58